Common Respiratory Infections in Rural India
{“title”:”Common Respiratory Infections in Rural India: Diagnosis, Treatment and Prevention”,”excerpt”:”An exhaustive guide for primary care physicians in rural India on the most frequent respiratory infections, their clinical testing protocols, antibiotic regimens, and cost‑effective preventive strategies.”,”content_html”:”n
In rural households across India, upper and lower respiratory tract infections (URTIs & LRTIs) remain the leading cause of morbidity, especially among children and the elderly. The high prevalence is driven by overcrowded living conditions, seasonal humidity, limited access to clean water, and a scarcity of trained healthcare workers. This article provides a detailed, evidence‑based framework for diagnosing, treating and preventing these infections in resource‑constrained settings.
n
1. Acute Otitis Media (AOM)
n
- n
- Clinical Features: Ear pain, fever >38°C, bulging tympanic membrane on otoscopy.
- Diagnostic Tests: Simple otoscopic examination is usually sufficient. In doubtful cases, pneumatic otoscopy or tympanometry can be used if available.
- Antibiotic Options: n
- n
- Doxycycline 10 mg/kg/day in two divided doses for 7–10 days (safe after age 8).
- Amoxicillin 80–90 mg/kg/day in two divided doses for 7 days (first line).
- Amoxicillin‑clavulanate 80–90 mg/kg/day in two divided doses for 7 days if risk of resistance.
n
n
n
- Preventive Measures: Hand hygiene, avoidance of tobacco smoke, timely vaccination with pneumococcal conjugate vaccine (PCV13) where available.
n
n
n
n
n
2. Acute Bronchitis
n
- n
- Clinical Features: Productive cough lasting <4 weeks, wheeze, low‑grade fever.
- Diagnostic Tests: Chest auscultation; in suspected bacterial cases, sputum Gram stain if available.
- Antibiotic Options: n
- n
- Amoxicillin 80–90 mg/kg/day for 7 days if bacterial etiology suspected.
- Azithromycin 5 mg/kg on day 1 followed by 2.5 mg/kg/day for 4 days if atypical pathogens considered.
n
n
- Preventive Measures: Smoke-free environment, hand washing, influenza & pneumococcal vaccination for high‑risk groups.
n
n
n
n
n
3. Pneumonia (Community‑Acquired)
n
- n
- Clinical Features: Fever >38°C, tachypnea (>30 breaths/min in children <5 yrs), chest indrawing.
- Diagnostic Tests: n
- n
- Clinical diagnosis (WHO IMCI criteria) is primary.
- Chest X‑ray if available (look for consolidation).
- PCR or GeneXpert MTB/RIF if tuberculosis suspected.
n
n
n
- Antibiotic Options: n
- n
- First line: Amoxicillin 80–90 mg/kg/day in two divided doses for 7–10 days.
- For severe cases or when resistance suspected: Ceftriaxone 50 mg/kg/day IM/IV for 7 days.
- If TB confirmed: Category I DOTS regimen (HRZE for 2 months followed by HR for 4 months).
n
n
n
- Preventive Measures: Bacillus Calmette‑Guérin (BCG) vaccination at birth, pneumococcal conjugate vaccine for children <5 yrs, influenza vaccine annually for high‑risk groups, nutritional supplementation (vitamin A & zinc).
n
n
n
n
n
4. Chronic Obstructive Pulmonary Disease (COPD) Exacerbation
n
- n
- Clinical Features: Increased dyspnea, sputum purulence and volume.
- Diagnostic Tests: Spirometry (FEV1/FVC <0.70) if available; peak flow monitoring otherwise.
- Antibiotic Options: n
- n
- Amoxicillin‑clavulanate 80–90 mg/kg/day for 7 days if bacterial infection suspected.
- Azithromycin 5 mg/kg day 1, then 2.5 mg/kg/day for 4 days as a macrolide alternative.
n
n
- Preventive Measures: Smoking cessation, avoidance of biomass fuel smoke, indoor air purification (e.g., LPG stoves), vaccination with influenza & pneumococcal vaccines.
n
n
n
n
n
5. Tuberculosis (TB) – Pulmonary & Extrapulmonary
n
- n
- Diagnostic Tests: n
- n
- Chest X‑ray: Cavitary lesions, upper lobe infiltrates.
- GeneXpert MTB/RIF: Rapid detection of M. tuberculosis and rifampicin resistance (cost‑effective in district hospitals).
- Sputum smear microscopy (Ziehl–Neelsen) for initial screening.
- Interferon‑γ release assay (IGRA) or Mantoux test for latent TB.
n
n
n
n
- Antibiotic Regimen: n
- n
- Category I DOTS (HRZE for 2 months, HR for 4 months).
- For drug‑resistant TB: Linezolid, bedaquiline or delamanid as per national guidelines and drug susceptibility testing.
n
n
- Preventive Measures: BCG at birth, contact tracing, IPT with isoniazid 300 mg daily for 6 months in high‑risk contacts, improved ventilation in homes.
n
n
n
n
6. Viral Upper Respiratory Tract Infections (Common Cold, Influenza)
n
- n
- Diagnostic Tests: Clinical diagnosis; rapid influenza diagnostic test (RIDT) if available.
- Treatment: Symptomatic relief – paracetamol 15 mg/kg every 6–8 hrs; decongestants (if age >5 yrs). Antiviral oseltamivir 30 mg/day for 5 days if influenza confirmed and within 48 hrs of onset.
- Prevention: Hand hygiene, face masks during peak season, influenza vaccine annually for ≥6 yrs and high‑risk groups.
n
n
n
n
7. Asthma Exacerbation (Acute)
n
- n
- Diagnostic Tests: Peak flow monitoring; if available, spirometry.
- Treatment: n
- n
- Short‑acting β2‑agonist (SABA) – Salbutamol 100 µg inhalation every 5–15 min up to 4 times a day.
- Systemic corticosteroid – Prednisolone 1 mg/kg/day for 5 days.
- If severe: Intravenous methylprednisolone 40 mg/kg/day for 3 days.
n
n
n
- Prevention: Avoidance of known triggers (dust, smoke), regular use of inhaled corticosteroids if prescribed, vaccination against pneumococcus and influenza.
n
n
n
n
8. Post‑viral Cough & Bronchitis (Persistent >3 weeks)
n
- n
- Diagnostic Tests: Chest X‑ray to rule out bacterial superinfection; sputum culture if purulent.
- Treatment: Symptomatic – cough suppressants (dextromethorphan 0.6 mg/kg every 8 hrs) for dry cough; mucolytics (acetylcysteine 10 mg/kg/day). Avoid antibiotics unless bacterial evidence.
- Prevention: Smoking cessation, humidified air, adequate hydration.
n
n
n
n
Practical Implementation in Rural Settings
n
- n
- Task‑shifting: Train community health workers (ASHA) in basic otoscopy, pulse oximetry and sput